Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
272 participants
OBSERVATIONAL
2020-11-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analyzing Composition and Lubrication Properties of Synovial Fluid
NCT00912106
The Role of Synovectomy in Pain Reduction Following Total Knee Arthroplasty
NCT05800457
Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee Osteoarthritis
NCT02070224
Evaluation of Patients With Knee Osteoarthritis Receiving a Prosthesis
NCT03644420
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
NCT05737173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergone TKA due to advanced knee osteoarthritis
Total knee arthroplasty due to advanced osteoarthritis.
Postoperative usage of intravenous methylprednisolone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total knee arthroplasty due to advanced osteoarthritis.
Postoperative usage of intravenous methylprednisolone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
55 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Hospital of Qingdao University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiang Shuai, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The affiliated hospital of Qingdao University
Qingdao, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OASynoviumAHQD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.